Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Jones Lang LaSalle | JLL | Jan 30, 2025 | 282.34 | +1.15 |
Journey Medical | DERM | Jan 30, 2025 | 3.98 | +1.02 |
Jowell Global | JWEL | Jan 30, 2025 | 2.90 | +4.69 |
JOYY ADR | YY | Jan 30, 2025 | 45.24 | +2.24 |
JP Morgan Chase | JPM | Jan 30, 2025 | 268.23 | +0.62 |
JP Morgan Chase & Co EE Pref | JPM-C | Jan 30, 2025 | 25.17 | -1.06 |
JP Morgan Chase & Co GG Pref | JPM-J | Jan 30, 2025 | 21.33 | -0.74 |
JP Morgan Chase & Co Ser DD Pref | JPM-D | Jan 30, 2025 | 25.02 | -1.30 |
JPMorgan Nasdaq Equity Premium Income ETF | JEPQ | Jan 30, 2025 | 57.52 | +0.26 |
Jumia Technologies ADR | JMIA | Jan 30, 2025 | 4.21 | +6.58 |
Junee Limited - Ordinary Shares | JUNE | Jan 30, 2025 | 4.00 | +8.99 |
Junior Gold Miners ETF Market Vectors | GDXJ | Jan 30, 2025 | 49.20 | +3.86 |
Juniper Networks | JNPR | Jan 30, 2025 | 34.38 | -2.19 |
Jupiter Neurosciences | JUNS | Jan 30, 2025 | 1.12 | 0.00 |
JVSPAC Acquisition | JVSAU | Jan 30, 2025 | 10.93 | 0.00 |
JVSPAC Acquisition | JVSA | Jan 30, 2025 | 10.58 | 0.00 |
JX Luxventure | JXG | Jan 30, 2025 | 2.70 | 0.00 |
Kadant | KAI | Jan 30, 2025 | 376.21 | +0.86 |
Kairos Pharma | KAPA | Jan 30, 2025 | 1.48 | -1.33 |
Kaiser Aluminium | KALU | Jan 30, 2025 | 70.73 | -0.59 |
Kaival Brands Innovations Group | KAVL | Jan 30, 2025 | 1.36 | +14.29 |
Kaixin Holdings | KXIN | Jan 30, 2025 | 1.41 | +2.92 |
Kala Bio | KALA | Jan 30, 2025 | 9.48 | +7.36 |
Kaltura | KLTR | Jan 30, 2025 | 2.29 | -0.43 |
KalVista Pharmaceuticals | KALV | Jan 30, 2025 | 8.77 | 0.00 |
Kamada | KMDA | Jan 30, 2025 | 6.71 | -0.45 |
Kandi Technologies Group | KNDI | Jan 30, 2025 | 1.16 | +4.50 |
Kanzhun ADR | BZ | Jan 30, 2025 | 15.37 | +4.27 |
Karat Packaging | KRT | Jan 30, 2025 | 31.61 | +2.03 |
Karooooo | KARO | Jan 30, 2025 | 47.01 | +3.34 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.